Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cancer
• Carcinoma
• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Head and Neck Cancer
• Kidney Cancer
• Lung Cancer
• Melanoma
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer
• Sarcoma
• Solid Tumor
• Thyroid Cancer
• Uterine Cancer

Drugs mentioned

• KVA12123
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Kineta Inc. | Conditions: Cancer, Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN